Holen Sie sich die Stockscreener-App
0.8859
5.09%
0.0429
Handel nachbörslich:
.91
0.0241
+2.72%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ASRT?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.843
Offen:
$0.8231
24-Stunden-Volumen:
743.65K
Relative Volume:
1.01
Marktkapitalisierung:
$84.58M
Einnahmen:
$169.43M
Nettoeinkommen (Verlust:
$-186.01M
KGV:
0.5986
EPS:
1.48
Netto-Cashflow:
$70.07M
1W Leistung:
-3.71%
1M Leistung:
-6.75%
6M Leistung:
-23.63%
1J Leistung:
-14.82%
1-Tages-Spanne:
$0.81
$0.9091
1-Wochen-Bereich:
$0.81
$0.96
52-Wochen-Spanne:
$0.7324
$1.798
Assertio Holdings Inc Stock (ASRT) Company Profile
Firmenname
Assertio Holdings Inc
Sektor
Telefon
(224) 419-7106
Adresse
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Vergleichen Sie ASRT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
0.8859 | 84.58M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-26 | Eingeleitet | Maxim Group | Buy |
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-11-07 | Eingeleitet | Lake Street | Buy |
| 2018-11-30 | Herabstufung | Mizuho | Buy → Neutral |
Assertio Holdings Inc Aktie (ASRT) Neueste Nachrichten
Assertio appoints new independent director to board By Investing.com - Investing.com South Africa
Assertio appoints new independent director to board - Investing.com
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors - The Manila Times
Assertio Holdings Taps Former Astellas President Who Led $5B Sales Growth to Join Board - StockTitan
Assertio’s (ASRT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Assertio Therapeutics shares get buy rating on clinical trial results By Investing.com - Investing.com Canada
Assertio (NASDAQ:ASRT) Receives Buy Rating from HC Wainwright - MarketBeat
Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 11.5% in November - MarketBeat
Assertio reports positive Rolvedon trial results for breast cancer By Investing.com - Investing.com Australia
Assertio Announces Results of Rolvedon (Eflapegrastim-Xnst) Injection Same-Day Dosing Clinical Study - Marketscreener.com
Assertio reports positive Rolvedon trial results for breast cancer - Investing.com
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study - The Manila Times
Assertio's Rolvedon Shows Promising Clinical Data in Breast Cancer Trial with Same-Day Chemo Dosing - StockTitan
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO - The Manila Times
Assertio Holdings Creates Transformation Office, Appoints New Leadership to Drive Growth Strategy - StockTitan
Assertio Holdings Inc (NASDAQ: ASRT): Blank Check On Growth? - Stocks Register
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewswire Inc.
Beam Therapeutics names Sravan K. Emany as new CFO - Investing.com
HC Wainwright Forecasts Stronger Earnings for Assertio - MarketBeat
Assertio shares hold price target, buy rating on stable Indocin share By Investing.com - Investing.com Canada
Assertio Holdings Q3 2024 Earnings Preview - MSN
Assertio stock gains amid Q3 earnings, clash with activist investor - MSN
Insider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires $60,000.00 in Stock - MarketBeat
Assertio Holdings director Heather Mason buys $60,000 in shares By Investing.com - Investing.com Nigeria
Assertio Holdings director Heather Mason buys $60,000 in shares - Investing.com
Assertio Holdings CEO Brendan O'Grady buys $9,950 in common stock - Investing.com India
Spectrum Pharma Faces Senate Probe Call Over Alleged Rolvedon Data Fraud | ASRT Stock News - StockTitan
Assertio Holdings Inc (ASRT) Quarterly 10-Q Report - Quartz
Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call Transcript - Insider Monkey
Assertio: Q3 Earnings Snapshot - The Washington Post
Assertio Therapeutics’ Q3 2024 Earnings Overview - TipRanks
Assertio stock gains amid Q3 earnings, clash with activist investor (NASDAQ:ASRT) - Seeking Alpha
Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Assertio Reports Third Quarter 2024 Financial Results - The Manila Times
Assertio Holdings, Inc. Announces Board Changes - Marketscreener.com
Assertio Holdings Faces SEC Whistleblower Complaint Over Alleged Clinical Data Fraud | ASRT Stock News - StockTitan
Assertio Provides Response to Letter from Short-seller - GlobeNewswire
Assertio Holdings CEO Fires Back at Short-Seller's 'Baseless' Rolvedon Claims | ASRT Stock News - StockTitan
Assertio Holdings (NASDAQ:ASRT investor five-year losses grow to 72% as the stock sheds US$17m this past week - Simply Wall St
Assertio faces fraud claims, investor goes short on stock By Investing.com - Investing.com India
Assertio Stock Alert: Major Investor Warns of Fraud Claims, Safety Issues in Spectrum Deal | ASRT Stock News - StockTitan
Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Sidoti Csr Issues Negative Forecast for Assertio Earnings - MarketBeat
Assertio (ASRT) Scheduled to Post Earnings on Monday - MarketBeat
ASRTAssertio Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024 - The Manila Times
Non-Steroidal Anti-Inflammatory Drugs Market Sees Robust Growth Amid Rising Demand | PLC, and Assertio - EIN News
Director Vacirca Jeff L acquire 10,000 shares of Assertio Holdings Inc [ASRT] - Knox Daily
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - GlobeNewswire
Finanzdaten der Assertio Holdings Inc-Aktie (ASRT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Assertio Holdings Inc-Aktie (ASRT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| O'Grady Brendan P. | CEO |
Nov 14 '24 |
Buy |
0.85 |
11,706 |
9,950 |
11,706 |
| Schlessinger Sam | SVP, General Counsel |
Oct 01 '24 |
Option Exercise |
0.00 |
19,404 |
0 |
141,459 |
| Vacirca Jeff L | Director |
Jun 11 '24 |
Buy |
1.11 |
10,000 |
11,100 |
151,159 |
| Mason Heather L | Interim Executive Officer |
Jun 05 '24 |
Buy |
0.97 |
25,000 |
24,250 |
212,650 |
| Schlessinger Sam | SVP, General Counsel |
May 12 '24 |
Option Exercise |
0.00 |
38,017 |
0 |
138,895 |
| Schwichtenberg Paul | SVP, CCO |
May 12 '24 |
Option Exercise |
0.00 |
38,017 |
0 |
141,941 |
| Patel Ajay | SVP and CFO |
May 12 '24 |
Option Exercise |
0.00 |
38,017 |
0 |
171,271 |
| Tyree James L | Director |
Mar 14 '24 |
Sale |
1.12 |
10,251 |
11,463 |
188,251 |
| Schlessinger Sam | SVP, General Counsel |
Feb 21 '24 |
Option Exercise |
0.00 |
17,151 |
0 |
109,384 |
| Schwichtenberg Paul | SVP, CCO |
Feb 21 '24 |
Option Exercise |
0.00 |
17,151 |
0 |
112,430 |
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):